Wisconsin and Minnesota kids know their math!
However, I might be alone in the lack of math skills here in the Upper Midwest. According to a study by Infinity Calculator, the Top 10 States Leading Math Proficiency. They analyzed mathematics scores from standardized tests to determine which states are outperforming others. Minnesota is 3rd and Wisconsin is 8th in Math Proficiency. The study combined average scores from the SAT, ACT, and National Assessment of Educational Progress Exams representing students from 4th grade through high school. On an index score of 100, Minnesota scored 74.01 and Wisconsin 71.87.
According to the CEO of Infinity Calculator, Jehan Wadia, 'Our study results showcase the importance of a strong foundation in mathematics across all education levels as the demand for STEM professionals continues to rise. It's encouraging to see the dedication to math proficiency across the US, as this is crucial for students' future success in a technology-driven world.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Commemorate 162nd anniversary of the Battle of Gettysburg with events, programs
GETTYSBURG, Pa. (WHTM) — Monday's Hometown Heroes are bringing Civil War history to life this week. Gettysburg National Military Park will commemorate the 162nd anniversary of the Battle of Gettysburg. The events will run from July 1 – July 3, marking the exact dates of the battle. Close Thanks for signing up! Watch for us in your inbox. Subscribe Now This year's commemoration includes a series of ranger-led programs, immersive battlefield walks, family activities and evening presentations by renowned historians. Events include: Daily Ranger-Guided Walks and Talks – Explore famed battle sites such as Devil's Den and Little Round Top through immersive hikes and tours with park rangers. Battle Walks – Experience key episodes of the battle through this 2-3 hour hike over rough terrain. Bring water, headgear and sturdy walking shoes. Sacred Trust Lecture Series – Listen to prominent historians and speakers discuss the events of 162 years ago through unique perspectives. Family Programs – Something for the kiddos. Special family programs provide an opportunity for families with children ages 4-14 to experience the battlefield in an educational and playful way. Lessons from the Battle of Gettysburg inspiring NASA leaders All events are free to attend. However, some may require tickets in advance. For a complete list and details of the events, click here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
What fireworks are legal in Pennsylvania?
(WHTM) — Pennsylvania is the birthplace of independence, but letting freedom ring comes with some restrictions. The Keystone state only allows consumers to purchase and use Class C, or consumer grade, fireworks. This includes firecrackers, Roman candles, bottle rockets and similar fireworks that contain a maximum of 50 milligrams of explosive material. Close Thanks for signing up! Watch for us in your inbox. Subscribe Now Display fireworks are only to be used by professionals with a permit from the municipality in which the display will take place. Display fireworks include products that contain more than two grains or 130 milligrams of explosive material and aerial shells containing more than 60 grams of pyrotechnic compositions Anyone 18 years or older can purchase, possess and use consumer fireworks. Fireworks cannot: be ignited or discharged on public or private property without express permission of the property owner be directed at another person be discharged from or directed at a building or vehicle be discharged within 150 feet of a building or vehicle regardless if the building or vehicle is owned by the user of the consumer fireworks be discharged while the person is under the influence of alcohol, a controlled substance or another drug Commemorate 162nd anniversary of the Battle of Gettysburg with events, programs Typically restrictions that allow municipalities to restrict the use of consumer fireworks between 10 p.m. and 10 a.m. do not apply on July 2, 3 and 4. Instead, they can be lit until 1 a.m. Other municipal restrictions still apply, so always make sure to check local ordinances before choosing to celebrate with fireworks. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Business Wire
20 hours ago
- Business Wire
Natera to Present Clinical and Economic Utility of Signatera at ESMO GI, Highlights Innovations in MRD
AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, announced new data that will be presented at the 2025 European Society for Medical Oncology GI Congress (ESMO GI) in Barcelona, Spain. These presentations reinforce the strong clinical and economic utility of Signatera™ monitoring across colon and rectal cancers (CRC), as well as new clinical validation data on its tissue-free MRD assay. Signatera in CRC surveillance Data on >3,000 CRC patients will be shared in an oral presentation, concluding that adding Signatera ctDNA * monitoring to the current standard of care in surveillance can better identify patients who are candidates for metastasis-directed therapy (MDT). Results indicated that Signatera-positive patients were up to 20x more likely to receive curative-intent MDT than Signatera-negative patients. By comparison, CEA positivity led to only a 2x increase, with no added value in stage IV. Signatera Genome in rectal cancer An analysis will be presented from the MD Anderson INTERCEPT study (n=31) that used serial Signatera Genome testing in patients with locally advanced rectal cancer after neoadjuvant therapy. Results demonstrated 100% specificity/PPV, with surveillance sensitivity of 100% in the surgical cohort and 88% (7/8) overall. Economic utility of Signatera-guided therapy in adjuvant CRC A budget impact model from BUPA, a multinational health insurance provider with over 60 million customers, will outline a 43% expected reduction in healthcare costs using Signatera-guided adjuvant treatment versus standard of care in stage II-III CRC. 'We're excited to present these new findings that continue to support the utility of Natera's products across GI cancers,' said Adham Jurdi, M.D., senior medical director of oncology at Natera. 'These data highlight our commitment to improving outcomes and driving innovation in MRD detection.' Full list of data featuring Natera's technology at ESMO GI: July 4, 16:40-16:50 CET | FPN: 20 | Signatera (Oral Presentation) Presenter: Arvind Dasari, M.D., MS Clinical utility of including circulating tumor DNA (ctDNA) monitoring in standard of care (SoC) colorectal cancer (CRC) surveillance July 4, 16:50-17:00 CET | FPN: 30 | Signatera (Oral Presentation) Presenter: Hideaki Bando, M.D. Association of ctDNA Clearance with Disease-Free Survival and Safety and Quality of Life from ctDNA-Directed Therapy: Findings from the ALTAIR Study July 4, 15:30-16:30 CET | FPN: 102P | Signatera (Poster Presentation) Presenter: Christos Mikropoulos, MBBS, MSc, M.D. (Res), MRCP, FRCR Direct cost of healthcare analysis of Signatera ctDNA testing in the adjuvant setting for a hypothetical cohort of stage II and stage III colorectal cancer (CRC) patients: a UK private payer perspective July 4, 15:30-16:30 CET | FPN: 243P | Signatera Genome (Poster Presentation) Presenter: Arvind Dasari, M.D., MS Clinical performance of Signatera Genome assay in a sub-cohort of locally advanced rectal cancer (LARC) patients (pts) in the MD Anderson INTERCEPT program July 4, 15:30-16:30 CET | FPN: 93P | Tissue-free MRD (Poster Presentation) Presenter: Yoshiaki Nakamura, M.D., Ph.D. Clinical validation of a methylation-based, tissue-free colorectal cancer test for the detection of molecular residual disease by circulating tumor DNA July 4, 15:30-16:30 CET | FPN: 89P | Early Cancer Detection (Poster Presentation) Presenter: John P.Y. Shen, M.D. Development of methylation-based biomarkers to predict metastases, treatment effect, and microsatellite status in colorectal cancer Notes * Circulating tumor DNA About Natera Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women's health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera's tests are supported by more than 300 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California. For more information, visit Forward-Looking Statements All statements other than statements of historical facts contained in this press release are forward-looking statements and are not a representation that Natera's plans, estimates, or expectations will be achieved. These forward-looking statements represent Natera's expectations as of the date of this press release, and Natera disclaims any obligation to update the forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including with respect to whether the results of clinical or other studies will support the use of our product offerings, the impact of results of such studies, our expectations of the reliability, accuracy and performance of our tests, or of the benefits of our tests and product offerings to patients, providers and payers. Additional risks and uncertainties are discussed in greater detail in 'Risk Factors' in Natera's recent filings on Forms 10-K and 10-Q and in other filings Natera makes with the SEC from time to time. These documents are available at and
